Q32 Bio, Inc. (QTTB)
8.23
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
8.24
+0.01
(+0.12%)
After-Hours: 20:00
Q32 Bio Price to Book Value : 1.845 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.845 |
| October 01, 2026 | 1.849 |
| September 30, 2026 | 1.854 |
| September 29, 2026 | 2.136 |
| September 28, 2026 | 2.069 |
| September 25, 2026 | 1.966 |
| September 24, 2026 | 2.066 |
| September 23, 2026 | 2.143 |
| September 22, 2026 | 2.369 |
| September 21, 2026 | 2.347 |
| September 18, 2026 | 2.362 |
| September 17, 2026 | 2.434 |
| September 16, 2026 | 2.461 |
| September 15, 2026 | 2.504 |
| September 14, 2026 | 2.445 |
| September 11, 2026 | 2.488 |
| September 10, 2026 | 2.403 |
| September 09, 2026 | 2.497 |
| September 08, 2026 | 2.620 |
| September 04, 2026 | 2.687 |
| September 03, 2026 | 2.869 |
| September 02, 2026 | 3.046 |
| September 01, 2026 | 3.218 |
| August 31, 2026 | 3.333 |
| August 28, 2026 | 3.369 |
| Date | Value |
|---|---|
| August 27, 2026 | 3.620 |
| August 26, 2026 | 3.626 |
| August 25, 2026 | 3.658 |
| August 24, 2026 | 3.667 |
| August 21, 2026 | 3.579 |
| August 20, 2026 | 3.555 |
| August 19, 2026 | 3.550 |
| August 18, 2026 | 3.427 |
| August 17, 2026 | 3.575 |
| August 14, 2026 | 3.396 |
| August 13, 2026 | 3.445 |
| August 12, 2026 | 3.445 |
| August 11, 2026 | 3.454 |
| August 10, 2026 | 3.512 |
| August 07, 2026 | 3.496 |
| August 06, 2026 | 3.631 |
| August 05, 2026 | 3.696 |
| August 04, 2026 | 3.621 |
| August 03, 2026 | 3.399 |
| July 31, 2026 | 3.514 |
| July 30, 2026 | 3.488 |
| July 29, 2026 | 3.281 |
| July 28, 2026 | 3.521 |
| July 27, 2026 | 3.409 |
| July 24, 2026 | 3.396 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Intellia Therapeutics, Inc. | 2.359 |
| Beam Therapeutics, Inc. | 2.370 |
| Prime Medicine, Inc. | 13.53 |
| Prelude Therapeutics, Inc. | 2.189 |
| Twist Bioscience Corp. | 26.53 |
Price to Book Value Related Metrics
| PE Ratio | 2.742 |
| PS Ratio | 2.269 |
| Price | 8.23 |
| Earnings Yield | 36.47% |
| Market Cap | 195.35M |
| Operating PE Ratio | 5.682 |
| Normalized PE Ratio | 2.738 |